Birdwatch Note
2022-04-26 11:08:09 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Ivermectin is not approved by the FDA for the treatment of any viral infection. https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/
Written by 5A703A6A5BE07AA0FC505BEA9E146058
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1518738126012887040
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1518909794681249793
- noteId - 1518909794681249793
- participantId - 5A703A6A5BE07AA0FC505BEA9E146058
- noteAuthorParticipantId -
- createdAtMillis - 1650971289689
- tweetId - 1518738126012887040
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - EASY
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Ivermectin is not approved by the FDA for the treatment of any viral infection. https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2022-04-26 11:08:09 UTC (1650971289689) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
0E1F05690AAF83EA44AD4E5773A5E6256508C3FE93F2A359831142A5E7AF91EC | ||
2022-04-26 11:08:09 UTC (1650971289689) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
5A703A6A5BE07AA0FC505BEA9E146058 |
Note Ratings
rated at | rated by | |
2022-04-26 07:11:26 -0500 | 024E9C2132658F6D841C91835F8192FF6C242BFDA2429E49A78D9C2300A66834 | Rating Details |
2022-04-26 07:47:32 -0500 | 06C1BFBA3D3C1638AD9CF88D123D6D38FBFC65859EE376FB46460CB417E88D8F | Rating Details |
2022-04-26 10:03:00 -0500 | 0C91900F7892D8DA899BB85193A8758A | Rating Details |
2022-04-26 08:15:35 -0500 | 0E55204C62321C2C52A11BB599C694C7 | Rating Details |
2022-04-26 07:29:39 -0500 | 0E6BE8C978905C9FA30B335A98569790121A221678E100029C7D1A0747982A35 | Rating Details |
2022-04-26 08:50:45 -0500 | 13B400DB04AFD8974DDA29778FAEF60C | Rating Details |
2022-04-26 06:33:15 -0500 | 148C0404C5C6CBCA49B53AA83F421336 | Rating Details |
2022-04-26 16:40:41 -0500 | 178D0FC1A1907F41A781B5F9C166A782 | Rating Details |
2022-04-26 09:28:03 -0500 | 18F650149F79419AE5835C8CFCBF6034 | Rating Details |
2022-04-26 07:47:32 -0500 | 1F2003F9E656505CDDD213F084581EA6 | Rating Details |
2022-04-27 00:12:19 -0500 | 20D08FD316C35B9001300D92F4F50E06 | Rating Details |
2022-04-27 07:42:09 -0500 | 238938F8A35959DAFA9518817DEB65AA | Rating Details |
2022-04-26 08:02:19 -0500 | 2634547E7591E4C3B9D09B4A1D504D3255EDACCA4C2B70A51920B595F70176D8 | Rating Details |
2022-05-13 13:32:18 -0500 | 306C001FB157171615E1F826F2B1DC71 | Rating Details |
2022-04-26 08:25:55 -0500 | 3517B20DB0798FE53CC8DAC0CF4C3A0A35A76B4C38F47B9359CFC38F90970FF0 | Rating Details |
2022-04-26 11:34:15 -0500 | 40207DE86D2E8AD9FD85726281BA80AEBBDF045DC3DC40942C20C778DB8DF934 | Rating Details |
2022-04-26 08:25:55 -0500 | 42AEF5A8B32EE2FC70F7C0AAB49345F9 | Rating Details |
2022-04-26 07:26:40 -0500 | 46811968F3A042290F00BC78D7965B35 | Rating Details |
2022-04-26 08:15:35 -0500 | 5316003777A052FABD697808CEB09E30CAD2C9CAC0A5359F6BB9B8785C8CDD1B | Rating Details |
2022-04-26 08:17:26 -0500 | 54A9F88B9D29B7CD06FDD25489A1798F | Rating Details |
2022-04-26 06:55:23 -0500 | 58C5E048EBCCED3EC652594B93CC80F2E29B49A777078F6DEE32C904E54787BA | Rating Details |
2022-04-26 07:26:40 -0500 | 5C9AFCD93BF3DACA19221A2D384B2DE6558442C8FBC27480E8B03302EAE07228 | Rating Details |
2022-04-26 08:16:26 -0500 | 5D8F1AB158A1BE038E392DAABB79CBE1B19E1ECFB109EB779B037033EA1B4B2C | Rating Details |
2022-04-26 07:10:21 -0500 | 5DB8F3CB244AAD6FEDD3F5C6EC43D1F6 | Rating Details |
2022-04-26 06:55:23 -0500 | 67F0A7CDB9281C5CB0AD73A4D6039662 | Rating Details |
2022-04-26 15:28:38 -0500 | 6E8386CA55C72EA800BB223639A38A25 | Rating Details |
2022-04-26 06:47:48 -0500 | 6FE967971F633416C6B991BB9680FB03 | Rating Details |
2022-04-26 07:11:26 -0500 | 74EE8436E0D8E1B5FFB970FB67DC2FAD | Rating Details |
2022-05-13 13:32:18 -0500 | 7ACFC241269ACF463C8AFEC7B840E5BE0F5AD92BBFA3C42757299F9311499390 | Rating Details |
2022-04-26 06:12:12 -0500 | 7EDA3904E35101EAF8BD30717C6CDEAF | Rating Details |
2022-04-26 13:20:51 -0500 | 811FD0671B5B1D7319C0D22A3D62CEE7240E75B42D8C6CEACF0E56E07F33735B | Rating Details |
2022-04-26 08:22:30 -0500 | 84CDB571D016BF9AC1A3FD393E494D2F66546EA9ECD8EAE3CBDF2FB1BC5A7F9C | Rating Details |
2022-04-26 11:34:15 -0500 | 8584AA58BA77CF8B37AF6D0B1ECAF4C9 | Rating Details |
2022-04-26 15:28:38 -0500 | 87C87E2381243E85AFF00A737F8FF6AA0EE64C1C924583BD3D9AD5CF327A2136 | Rating Details |
2022-04-26 08:19:43 -0500 | 8D863E6BDCB5FC79FBD564167A126D7E3181F0E92AB6B38EA59257DBE3EA0B92 | Rating Details |
2022-04-26 08:02:19 -0500 | 8EB9616EC1ED31C65C860C0C1471638E | Rating Details |
2022-04-27 00:12:19 -0500 | 91D0A3C20803E778A0FC2650A8DDE4AB685A7B5DB3A30DA88F57D8CE54384626 | Rating Details |
2022-04-26 08:16:26 -0500 | 95EA2DDF3AB881F5D990B40D911805AB | Rating Details |
2022-04-27 07:42:09 -0500 | 9736DF42171A999208E640D9616E3AF1D2219C9694E38F806D374F891F58485E | Rating Details |
2022-04-26 08:29:03 -0500 | 975236A4E88159934D823A96DD27D6D6 | Rating Details |
2022-04-26 06:12:12 -0500 | 994AD3ED674F42BEDE118612F7645BBF859B14F7FB531557A19201DF41523DBD | Rating Details |
2022-04-26 08:06:19 -0500 | 9DEDE74E99DBA8AF5A38539FDB053BB22ABE1016966420DF550C8212F7AE21C5 | Rating Details |
2022-04-26 10:03:00 -0500 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
2022-04-26 07:46:57 -0500 | ADD45E456AB7D426B6285A4072CC0CD7FCFE4053E48D5208D10198B94F6EB093 | Rating Details |
2022-04-26 09:28:03 -0500 | B41247447CF0EC824B15AEE3CC37FE478E1F6822AFA1C4AF60487E7916916176 | Rating Details |
2022-04-26 06:33:15 -0500 | B59F3D617E4A4CC54A244CC848F780367084AB5CC54C9D05B0058C63166BC866 | Rating Details |
2022-04-26 08:21:34 -0500 | B5ADB8E570319735EBA2877D0A1159BC18D28D8FB6CF651E23C5CDB732E13230 | Rating Details |
2022-04-26 06:14:48 -0500 | BFFCCF2B04328315CB4924B20B1246B6AAF7B499445EE7FEDDB4FECC9713DBA7 | Rating Details |
2022-04-26 08:31:38 -0500 | C0DEE1D3AD41EC68684A356B0CEF8126C0BA3B35559E39DEF3D9E270EF43AEF4 | Rating Details |
2022-04-26 08:17:26 -0500 | C1D15F774AF1C4ECE9E0BCFB5A544361957CE73086ED6B09FFAEF704AC06AB8A | Rating Details |
2022-04-26 13:20:51 -0500 | C9905E8111B07C9A3B38495BA98D9186 | Rating Details |
2022-04-26 08:21:34 -0500 | C9B69DA6E2C7F721AC7C0C32E2A82DF4 | Rating Details |
2022-04-26 08:19:43 -0500 | CBF22B8F555EB9E73D996B04279A3A48 | Rating Details |
2022-04-26 08:06:19 -0500 | DD33135B67E7DD5281CA0295DF70508E | Rating Details |
2022-04-26 08:50:45 -0500 | E0AA7F473BCA220F74D45FC42C52DE18DF0193BF8E0143E52659601884F2C60B | Rating Details |
2022-04-26 07:10:21 -0500 | E343F092F0B44A6E8DEC7F3A16DFE90A5DA9F420CB1B9EDE2292D0B45E00C827 | Rating Details |
2022-04-26 08:31:38 -0500 | E8CBB6B3EFB35F93081E02596ACADAE3 | Rating Details |
2022-04-26 06:14:48 -0500 | E8E0F69CB9CF54B6D447866C74982215 | Rating Details |
2022-04-26 08:29:03 -0500 | E9BD54B366D4926C7634CBA8916803085D6E3D1DAEAF0EE6E8FCF1D730A65A01 | Rating Details |
2022-04-26 07:46:57 -0500 | EEC3975062FC3D7610E2749BBE801748 | Rating Details |
2022-04-26 07:29:39 -0500 | F3081D7CBCA1FF55739647CC8ECE7859 | Rating Details |
2022-04-26 16:40:41 -0500 | F950A776C7DFAA426AC0277C9BCFB610FD3B76CABED2D9108D90BE4FF10D157F | Rating Details |
2022-04-26 08:22:30 -0500 | FCF4C955E9A29B92B7F662AC32E0394A | Rating Details |
2022-04-26 06:47:48 -0500 | FED73511F2BDB5E86905A1B066D6FDFAE369016A825E47935EF7CC1AE1CE000F | Rating Details |
2022-04-26 08:02:19 -0500 | Rating Details | |
2022-04-26 09:28:03 -0500 | Rating Details | |
2022-04-26 11:34:15 -0500 | Rating Details | |
2022-05-13 13:32:18 -0500 | Rating Details | |
2022-04-26 08:15:35 -0500 | Rating Details | |
2022-04-26 06:14:48 -0500 | Rating Details | |
2022-04-26 08:29:03 -0500 | Rating Details | |
2022-04-26 06:12:12 -0500 | Rating Details | |
2022-04-26 07:29:39 -0500 | Rating Details | |
2022-04-26 07:11:26 -0500 | Rating Details | |
2022-04-27 07:42:09 -0500 | Rating Details | |
2022-04-26 08:31:38 -0500 | Rating Details | |
2022-04-26 08:17:26 -0500 | Rating Details | |
2022-04-26 06:33:15 -0500 | Rating Details | |
2022-04-26 08:06:19 -0500 | Rating Details | |
2022-04-26 06:55:23 -0500 | Rating Details | |
2022-04-26 07:10:21 -0500 | Rating Details | |
2022-04-26 16:40:41 -0500 | Rating Details | |
2022-04-26 13:20:51 -0500 | Rating Details | |
2022-04-26 08:16:26 -0500 | Rating Details | |
2022-04-26 08:19:43 -0500 | Rating Details | |
2022-04-26 07:47:32 -0500 | Rating Details | |
2022-04-27 00:12:19 -0500 | Rating Details | |
2022-04-26 06:47:48 -0500 | Rating Details | |
2022-04-26 08:50:45 -0500 | Rating Details | |
2022-04-26 07:46:57 -0500 | Rating Details | |
2022-04-26 08:25:55 -0500 | Rating Details | |
2022-04-26 10:03:00 -0500 | Rating Details | |
2022-04-26 08:21:34 -0500 | Rating Details | |
2022-04-26 07:26:40 -0500 | Rating Details | |
2022-04-26 08:22:30 -0500 | Rating Details | |
2022-04-26 15:28:38 -0500 | Rating Details |